E-cadherin expression in skin tumors using an AMeX immunohistostaining method

Area of Science:

• Oncology
• Histopathology
• Immunohistochemistry

Background:

• The AMeX (acetone-methylbenzoate-xylene) method offers excellent tissue preservation and antigenicity, comparable to standard formalin fixation and fresh frozen specimens.
• Decreased E-cadherin expression is linked to increased invasive and metastatic potential in carcinomas.
• E-cadherin is a crucial cell-cell adhesion molecule.

Purpose of the Study:

• To evaluate the efficacy of the AMeX method for immunohistochemical analysis of E-cadherin expression in various skin tumors.
• To investigate the correlation between E-cadherin expression levels and the metastatic potential of basal cell carcinoma, squamous cell carcinoma, keratoacanthoma, and Bowen's disease.

Main Methods:

• Immunohistochemical staining using an anti-E-cadherin monoclonal antibody was performed on skin tumor specimens processed with the AMeX method.
• The AMeX method was utilized without the need for antigen retrieval.
• E-cadherin expression was assessed in 25 basal cell carcinomas, 11 squamous cell carcinomas, 9 keratoacanthomas, and 11 Bowen's disease cases.

Main Results:

• The AMeX method demonstrated effective antigen preservation for E-cadherin staining without pretreatment.
• Reduced E-cadherin expression was observed in 18.2% of squamous cell carcinomas and 33.3% of keratoacanthomas.
• High E-cadherin expression was maintained in nearly all cases of Bowen's disease and basal cell carcinoma.

Conclusions:

• The AMeX method is a valuable technique for immunohistochemical studies of skin tumors, preserving both morphology and antigenicity.
• Basal cell carcinoma and Bowen's disease exhibit high E-cadherin expression, suggesting a lower metastatic potential.
• Further applications of the AMeX method in immunohistochemistry are recommended due to its utility.